Further exploration of the interactions between lipid metabolism regulators (such as AMPK, PPARs, and LXR) and immune checkpoints may reveal novel pathways and potential therapeutic targets for ASO management
While it is portrayed as a miracle weight loss drug, there is the dark side of its serious side effects like stomach paralysis affecting thousands of people
Semaglutide reduces hunger, but it doesn't create weight loss aloneit makes eating less easier
Cagrilintide the Phase 2 monotherapy trial studied once-weekly doses of 0.3, 0.6, 1.2, 2.4, and 4.5 mg with a dose-escalation period
Best fit Gastric Sleeve Often a strong option for many first-time surgery patients without severe reflux
Insurers needed solutions that worked within the fiscal year, not across decades